Orexigen Therapeutics Inc. said Monday it is in discussions with the Food and Drug Administration about speeding up a regulatory review of Orexigen's obesity drug Contrave.

Eli Lilly and Co.'s potential once-weekly treatment for type 2 diabetes fared better than three other drugs in lowering blood sugar levels, according to initial results from some late-stage research.

The party that runs the Senate next year may be decided by how well President Barack Obama and Mitt Romney do in toss-up states like Nevada, Ohio, Virginia and Wisconsin, where ballots feature parallel Senate races about as tight as the presidential contest.

Diane Braunstein joins Pension Benefit's Quality Management department and Philip R. Langham joins the Benefits and Payment department.